These findings suggest that removing ACSL4-dependent ferroptosis in hepatocytes has no effect on tumor initiation but significantly and markedly impairs tumor growth and progression in an HCC model driven by prolonged toxic liver injury. Here, ACSL4 is linked to hepatocellular carcinoma.